About Isolere Bio
Isolere Bio is a Healthcare company based in Durham (United States) founded in 2017 by Joseph McMahon, Ashutosh Chilkoti, and Kelli Luginbuhl, and was acquired by Donaldson Company in February 2023. A platform for biotherapeutics purification is provided using TFF technology. Isolere Bio has raised $7 million across 7 funding rounds from investors including Donaldson Company, HHS and NCBiotech. Its chief executive, as recorded, is Kelli Luginbuhl. Isolere Bio offers products and services including IsoTagâ„¢ AAV and IsoTagâ„¢ LV. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Biologics Purification. Its legal entity is Isolere Bio, Inc. Its competitors include Zepteon, VIRAPUR and GenTegra; 1 of its 3 listed competitors has raised funding.
Company details
Isolere Bio was founded in 2017 and is located in Durham, United States. A platform for the purification of biotherapeutics is offered, centered on tangential flow filtration (TFF) technology. Antibodies and adeno-associated viruses are developed and manufactured through this simplified TFF method within the biotechnology sector. Operations support the creation of new drugs and diagnostics by streamlining purification processes for biopharmaceutical applications.
- Headquarters Durham, United States
- Founders Joseph McMahon, Ashutosh Chilkoti, Kelli Luginbuhl
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website isolerebio.com
- Social LinkedIn
- Acquired by Donaldson Company (Feb 2023)
- Legal Name Isolere Bio, Inc.
- Total Equity Funding$7M (USD)
in 7 rounds
- Latest Funding Round$255.56K (USD), Grant
Feb 2022
- InvestorsDonaldson Company
& 4 more
- Acquired byDonaldson Company
(Feb 2023)
Products & Services of Isolere Bio
Isolere Bio offers a comprehensive portfolio of products and services, including IsoTag™ AAV and IsoTag™ LV.
Reagent for high-yield AAV purification without chromatography.
Reagent for efficient lentiviral vector purification processes.
Funding Insights of Isolere Bio
Isolere Bio has successfully raised a total of $7M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $255.56 thousand completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7M
- Total Rounds 7
- Last Round Grant — $255,556
- First Round $1.72M
(Aug 2018)
- Investors Count 4
All 7 funding rounds of Isolere Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $255,556 | Grant | – | – | |
| Sep 2021 | $255,516 | Grant | – | – | |
| May 2021 | $7M | Seed | – | Northpond Ventures | – |
| May 2021 | $892,669 | Grant | – | – | |
| Jun 2019 | $250,000 | Debt – Conventional | – | – | |
| Feb 2019 | $269,999 | Grant | – | – | |
| Aug 2018 | $1.72M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Isolere Bio
Isolere Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Donaldson Company, HHS and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Biotech startups are incubated and funded in North Carolina. | 1984 | ncbiotech.org | Durham, United States | |
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Filtration systems are manufactured and supplied globally by Donaldson Company. | 1915 | donaldson.com | Gurugram, India |
Investor details for Isolere Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Isolere Bio
16 people are tracked at Isolere Bio (7 in leadership, 1 in board & advisors, 8 in team).
| Name | Role | Group |
|---|---|---|
Joseph McMahon | Co-Founder | Leadership |
Ashutosh Chilkoti | Co-Founder | Leadership |
Kelli Luginbuhl | Co-Founder & CEO | Leadership |
Nikki Votaw | Associate Director, R&d | Leadership |
Michael Dzuricky | Chief Scientific Officer | Leadership |
Kimberly Anderson | Director of Commercial R&D | Leadership |
Rhonda Stanley | Chief Financial Officer | Leadership |
Daniel Janse | Director | Board & advisors |
Linus Hyun | Principal Scientist | Team |
James A. McGuiness, PhD | Principal Scientist | Team |
Reetu Singh | Lab & Office Manager | Team |
Mauri Belasko | Senior Scientist | Team |
Shaleen Shrestha | Senior Scientist | Team |
Alyssa Wheeler | Scientist II | Team |
Saurabh Mehta, Ph.D. | Senior Research Scientist-Protein | Team |
Jb Jones | Research Scientist | Team |
Complete people profiles for Isolere Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Isolere Bio
4 dated milestones of Isolere Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Isolere Bio is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Grant, of $256K.
- Exit Acquired by Donaldson Company.
Competitors of Isolere Bio
Isolere Bio has 3 listed competitors in our database, 1 of them funded. They include Zepteon, VIRAPUR and GenTegra.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zepteon.com | 2012 | Boston, United States | $210,000 | Biomolecular separation tools for antibody potency evaluation are developed. | ||
| virapur.com | 2000 | San Diego, United States | Provides viral reagents and assay services for scientific and medical research. | |||
| gentegra.com | 2013 | Pleasanton, United States | Nucleic acid stabilization products are developed by GenTegra. |
Detailed competitors of Isolere Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Isolere Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Isolere Bio
Complete news archive for Isolere Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Isolere Bio
Isolere Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Isolere Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Kelli Luginbuhl is the CEO of Isolere Bio, as recorded in our data. They have also founded this company.
Isolere Bio is a funded company, having raised a total of $7M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.72M, raised on Aug 2018.
Isolere Bio was founded in 2017 and is located in Durham, United States. A platform for the purification of biotherapeutics is offered, centered on tangential flow filtration (TFF) technology. Antibodies and adeno-associated viruses are developed and manufactured through this simplified TFF method within the biotechnology sector. Operations support the creation of new drugs and diagnostics by streamlining purification processes for biopharmaceutical applications.
Isolere Bio offers IsoTagâ„¢ AAV and IsoTagâ„¢ LV.
Isolere Bio has 5 investors. Key investors include Donaldson Company, HHS, NCBiotech, Northpond Ventures, and America’s Seed Fund.
Isolere Bio operates through Isolere Bio, Inc..
Yes. Isolere Bio was acquired by Donaldson Company in February 2023.